Company Pay Ratios
Publicly traded companies are required to disclose the pay ratio between their chief executive officers and median employees. High CEO-to-worker pay ratios contribute to economic inequality and can undermine employee morale and productivity. The average S&P 500 company’s CEO-to-worker pay ratio was 272-to-1 in 2022.
Ticker | Company | Median Worker Pay Sort descending | Pay Ratio |
---|---|---|---|
KURA | Kura Oncology, Inc. | $308,704 | 17:1 |
TVTX | Travere Therapeutics, Inc. | $309,128 | 19:1 |
AGO | Assured Guaranty Ltd | $310,148 | 44:1 |
DCPH | Deciphera Pharmaceuticals, Inc. | $310,652 | 11:1 |
ARQT | Arcutis Biotherapeutics, Inc. | $310,773 | 15:1 |
RARE | Ultragenyx Pharmaceutical Inc. | $314,351 | 39:1 |
SNOW | Snowflake Inc. | $314,471 | 75:1 |
RBLX | Roblox Corp. | $315,140 | 4:1 |
SNDX | Syndax Pharmaceuticals Inc. | $316,414 | 13:1 |
GPMT | Granite Point Mortgage Trust Inc. | $318,450 | 12:1 |
CERE | Cerevel Therapeutics Holdings, Inc. | $318,973 | 35:1 |
INVA | Innoviva, Inc. | $319,745 | 6:1 |
EQS | Equus Total Return, Inc. | $325,746 | 3:1 |
LADR | Ladder Capital Corp. | $325,885 | 38:1 |
NLY | Annaly Capital Management Inc. | $335,000 | 43:1 |
RPRX | Royalty Pharma PLC | $337,085 | 277:1 |
KYMR | Kymera Therapeutics, Inc. | $341,869 | 20:1 |
OWL | Blue Owl Capital Inc. | $342,507 | 30:1 |
CPRX | Catalyst Pharmaceuticals, Inc. | $343,631 | 20:1 |
CIM | Chimera Investment Corp. | $345,000 | 17:1 |
Pagination
NOTE: For companies with more than one CEO during the year, the highest-paid CEO is included in the database. Pay ratio between CEO pay and median employee pay are displayed as disclosed by each company’s proxy statement. The CEO pay ratio may not equal the displayed CEO’s total compensation due to differing company methodologies in calculating pay ratios.
Terms and Data Sources | Contact the Press Office